A combination of two human neutralizing antibodies prevents SARS-CoV-2 infection in rhesus macaques
Ronald R. Cobb(Fisher Bioservices (United States)), James E. Crowe(Vanderbilt University Medical Center), Christopher G. Earnhart(United States Department of Defense), Genevieve H. Nonet, Robert H. Carnahan(Vanderbilt University Medical Center), Brian Hoppe, Doris M. Snow, Kyal Hackett, Milan T. Tomic(Life Services (United States)), Pavlo Gilchuk(AstraZeneca (Japan)), Laura A. VanBlargan(Washington University in St. Louis), James C. Slaughter(Vanderbilt University Medical Center), Dan H. Barouch(Beth Israel Deaconess Medical Center), Rita E. Chen(Washington University in St. Louis), Abishek Chandrashekar(Beth Israel Deaconess Medical Center), Nicole M. Dorsey(United States Department of Defense), Michael Diamond(Washington University in St. Louis), Joseph P. Nkolola(Beth Israel Deaconess Medical Center), Manuel Hechenblaikner(Fisher Bioservices (United States)), Svetlana A. Hopkins(Logistics Management Institute (United States)), Robert V. House(The White House), Laura Collins(University of Iowa)
Cited by 0
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Itaconate Links Inhibition of Succinate Dehydrogenase with Macrophage Metabolic Remodeling and Regulation of Inflammation
|Cell Metabolism|2016|1.5k
Complete Mapping of Mutations to the SARS-CoV-2 Spike Receptor-Binding Domain that Escape Antibody Recognition
|Cell Host & Microbe|2020|1.2k